Bio-Rad Laboratories
BIO · NYSE
Bulios Fair Price
$319.16
15.5% downside
Current Price
$377.57
According to Bulios Fair Price, BIO is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Bio-Rad Laboratories is an American biotechnology and diagnostics company that provides a wide range of products and services for research, diagnostics, and industrial applications. The company specializes in molecular biology, immunology, diagnostics, protein analysis, and genetic research. Bio-Rad Laboratories manufactures instruments, reagents, and software for laboratories and research institutions, focusing on improving diagnostic and treatment options in areas such as oncology, infectious diseases, and genetic disorders. The company is known for its innovative technology and strong presence in the global scientific equipment market.
Sector
Healthcare
Industry
Medical - Devices
CEO
Norman D. Schwartz
Employees
7,450
Headquarters
Hercules
Upcoming events
Earnings
Upcoming earnings report